ACTUATE THERAPEUTICS, INC. Logo

ACTUATE THERAPEUTICS, INC.

Clinical-stage biopharma developing therapies for cancers with high unmet needs.

ACTU | US

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
1751 RIVER RUN, 76107 FORT WORTH

Description

Actuate Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing therapies for cancers with high unmet medical needs. The company's lead drug candidate is elraglusib, a novel, first-in-class small molecule inhibitor of glycogen synthase kinase-3 (GSK-3). Elraglusib is being developed for difficult-to-treat cancers, including metastatic pancreatic cancer. Its mechanism of action targets multiple molecular pathways involved in promoting tumor growth and resistance to conventional drugs. Additionally, it functions as a mediator of anti-tumor immunity by inhibiting immune checkpoints and regulating immune cell function. The company's goal is to develop therapies that can slow, stop, or shrink tumors with minimal adverse effects, thereby improving patient outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all ACTUATE THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ACTUATE THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ACTUATE THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BIOMARIN PHARMACEUTICAL INC Logo
A global biotechnology company developing therapies for rare, life-threatening genetic diseases.
United States of America
BMRN
BioMaxima S.A. Logo
Manufacturer and distributor of in-vitro diagnostics for clinical microbiology.
Poland
BMX
Biomea Fusion, Inc. Logo
A clinical-stage biopharma developing oral drugs for diabetes and obesity.
United States of America
BMEA
BIOMERICA INC Logo
Develops in-vitro diagnostic and therapeutic products for chronic diseases.
United States of America
BMRA
bioMérieux Logo
A global leader in in vitro diagnostics for clinical and industrial applications.
France
BIM
BiomX Inc. Logo
Clinical-stage company developing phage therapies to target harmful bacteria.
United States of America
PHGE
BIONEERCORPORATION Logo
Develops and manufactures molecular biology products for research and diagnostics.
South Korea
064550
BioNTech SE Logo
Biotechnology company developing immunotherapies for cancer and infectious diseases.
United States of America
BNTX
BioPorto Logo
An in vitro diagnostics company specializing in biomarkers for early kidney injury detection.
Denmark
BIOPOR
BIO-RAD LABORATORIES, INC. Logo
Develops and manufactures products for life science and clinical diagnostics markets.
United States of America
BIO

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.